NEWS 2025 Radiotracer targets key cancer biomarker for precision treatment A breakthrough in molecular imaging could transform how...

FDA Investigating Serious Risk of T-cell Malignancy Following BCMA-Directed or CD19-Directed Autologous Chimeric Antigen Receptor (CAR) T...

June 28, 2023 In general terms, “theranostics” is the fusing of diagnosis and therapy to treat a variety of cancers, including prostate,...